To make this process more efficient, many health systems have implemented a "dotphrase" or "smartphrase" that allows providers to pull the risk score into their clinical notes based on data stored in the electr
The ApoB Principle: ApoB-Containing Lipoproteins Are Causal in Atherogenesis Overwhelming High-Quality Evidence Shows That LDL-C- and ApoB-Lowering Reduces CV Risk A Tale of 3 Guidelines: Canada, United States, and Europe Lowering ApoB Particles is the Cornerstone of ASCVD Prevention: Moving Towa...
An alternative method for risk assessment is a coronary artery calcium (CAC) score. Many older women have zero CAC, which equates to low risk for ASCVD; these women can delay statin therapy for several years before re-scanning. When CAC is 1-99 Agatston units, risk is only borderline ...
this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common
Mediterranean Diet and Dyslipidemia Dyslipidemia is a primary cause of the atherosclerotic car- diovascular disease (ASCVD) [101]. In particular, the most atherogenic form has been associated with type 2 diabe- tes and insulin resistance conditions [102]. Dyslipidemia is characterized by elevated ...
- Coronary artery calcium score - Atherosclerotic Cardiovascular Disease (ASCVD) Risk Estimator -- an equation to calculate the 10-year future risk of a heart attack Based on these tests, your doctor will decide if you should be on a statin. (MORE: Vast majority o...
Doctors are advised to test patients with dengue-like symptoms, especially those who have traveled to a part of the world where the disease is common. HHS Finalizes Ban on EHR Information Blocking HHS has finalized the disincentives to prevent health care organizations from unreasonably ...
Molnupiravir (Lagevrio) is a potent ribonucleoside analog that blocks SARS-CoV-2 replication by acting as a competitive substrate of virally-encoded RNA-dependent RNA polymerase.
This approach is based not only on the strong proatherogenic role of this lipoprotein class, but also on the solid evidence demonstrating that LDL-lowering drugs, such as statins and more recently PCSK9 inhibitors, are able to significantly reduce the risk of ASCVD in patients with CKD [[23]...
2.What exactly is my next 10yrs or lifetime risk of a heart attack? You can calculate your next 10yr or lifetime heart attack risk from many risk calculators freely available from the internet. Eg •ASCVD risk calculator (www.cvriskcalculator.com) ...